India to Singapore: Ezetimibe Export Trade Route
India has recorded 353 verified shipments of Ezetimibe exported to Singapore, representing a combined trade value of $3.2M USD. This corridor is served by 31 active Indian exporters, with an average shipment value of $9.0K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 92% of total export value with 36 shipments worth $2.9M USD. On the buying side, ACCORD HEALTHCARE PTE LTD is the largest importer in Singapore with $2.8M USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, MEDREICH LIMITED — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Singapore Ezetimibe corridor is one of India's established pharmaceutical export routes, with 353 shipments documented worth a combined $3.2M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 92% of all export value, reflecting the consolidated nature of India's ezetimibe manufacturing sector.
Across 31 active suppliers, the average shipment value stands at $9.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 25.0%, placing it at rank #3 among India's top ezetimibe export destinations globally.
On the import side, key buyers of Indian ezetimibe in Singapore include ACCORD HEALTHCARE PTE LTD, ACCORD HEALTHCARE PTE LIMITED, ABBOT LABORATORIES PTE LTD and 59 others. ACCORD HEALTHCARE PTE LTD is the single largest importer with 29 shipments valued at $2.8M USD.
Route Characteristics
- Average transit30 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#3
- Annual growth+25.0%
- Demand growth+22.9%
- Regulatory ease68/100
Top 10 Indian Ezetimibe Exporters to Singapore
Showing top 10 of 31 Indian suppliers exporting Ezetimibe to Singapore, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $81.4K per shipment | 36 | $2.9M | 92.5% |
| 2 | INTAS PHARMACEUTICALS LTD Avg $83.5K per shipment | 1 | $83.5K | 2.6% |
| 3 | MEDREICH LIMITED Avg $5.7K per shipment | 13 | $74.4K | 2.3% |
| 4 | INTAS PHARMACEUTICALS LIMITED Avg $20.0K per shipment | 2 | $40.0K | 1.3% |
| 5 | GANPATI EXIM INC Avg $1.5K per shipment | 13 | $19.0K | 0.6% |
| 6 | ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED Avg $65 per shipment | 87 | $5.7K | 0.2% |
| 7 | DERRIC WOOD Avg $62 per shipment | 64 | $4.0K | 0.1% |
| 8 | LOTUS INTERNATIONAL Avg $3.6K per shipment | 1 | $3.6K | 0.1% |
| 9 | SHREE SSD PHARMA PRIVATE LIMITED Avg $1.5K per shipment | 2 | $3.0K | 0.1% |
| 10 | MOIRAE GENERICS PRIVATE LIMITED Avg $51 per shipment | 49 | $2.5K | 0.1% |
This table shows the top 10 of 31 Indian companies exporting ezetimibe to Singapore, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, MEDREICH LIMITED, INTAS PHARMACEUTICALS LIMITED , GANPATI EXIM INC, ALPHA-PHARMA HEALTHCARE PRIVATE LIMITED, DERRIC WOOD, LOTUS INTERNATIONAL, SHREE SSD PHARMA PRIVATE LIMITED, MOIRAE GENERICS PRIVATE LIMITED . INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 36 shipments worth $2.9M USD, giving it a 92% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Showing top 10 of 31 total Indian exporters on the India to Singapore Ezetimibe export route.
Top 10 Ezetimibe Importers in Singapore
Showing top 10 of 62 known buyers in Singapore receiving Ezetimibe shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ezetimibe in Singapore include ACCORD HEALTHCARE PTE LTD, ACCORD HEALTHCARE PTE LIMITED, ABBOT LABORATORIES PTE LTD, ACCORD HEALTHCARE PTE LTD , ABBOT LABORATORIES PTE LIMITED, among 62 total buyers. The largest importer is ACCORD HEALTHCARE PTE LTD, accounting for $2.8M USD across 29 shipments — representing 87% of all ezetimibe imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ACCORD HEALTHCARE PTE LTD | 29 | $2.8M | 87.3% |
| 2 | ACCORD HEALTHCARE PTE LIMITED | 4 | $204.3K | 6.4% |
| 3 | ABBOT LABORATORIES PTE LTD | 8 | $46.1K | 1.5% |
| 4 | ACCORD HEALTHCARE PTE LTD | 1 | $30.6K | 1.0% |
| 5 | ABBOT LABORATORIES PTE LIMITED | 5 | $28.3K | 0.9% |
| 6 | GOLDPLUS UNIVERSAL PTE LTD | 3 | $27.9K | 0.9% |
| 7 | TO THE ORDER., | 1 | $16.5K | 0.5% |
| 8 | GOLDPLUS UNIVERSAL PTE LTD | 1 | $9.4K | 0.3% |
| 9 | TO THE- | 6 | $8.2K | 0.3% |
| 10 | NA | 1 | $3.6K | 0.1% |
Showing top 10 of 62 Ezetimibe importers in Singapore on this route.
Top 10 Ezetimibe Formulations Imported by Singapore
Showing top 10 of 116 product formulations shipped on the India to Singapore Ezetimibe route, ranked by trade value
Singapore imports a wide range of ezetimibe formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUGS AND MEDI LIPEZ EZETIMIBE 10MG 3X10T(ACC-SIN) EACH UNCOATED TABLET CONTAINS:EZETIMIBE 10 MG — accounts for $2.4M USD across 2 shipments. There are 116 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUGS AND MEDI LIPEZ EZETIMIBE 10MG 3X10T(ACC-SIN) EACH UNCOATED TABLET CONTAINS:EZETIMIBE 10 MG | 2 | $2.4M | 77.0% |
| 2 | PHARMA DRUGS AND MEDI LIPEZ EZETIMIBE 10MG 3X10T(ACC-SIN) EACH UNCOATED TABLET CONTAINS: EZETIMIBE 10 MG | 14 | $140.8K | 4.4% |
| 3 | PH.DRU.& MED.: LIPEZ EZETIMIBE 10MG TABLETS EACH TABLETS CONTAINS: EZETIMIBE 10MG [3X10T PER PACK] | 1 | $92.0K | 2.9% |
| 4 | PHARMA DRUGS AND MEDI LIPEZ EZETIMIBE 10MG 3X10TACC-SIN AS PER INV | 1 | $83.5K | 2.6% |
| 5 | PHARMACEUTICAL DRUGS & MEDICINE LIPEZ EZETIMIBE 10MG 3X10T(ACC-SIN) EACH UNCOATED TABLET CONTAINS EZETIMIBE ##. 10 MG | 2 | $75.4K | 2.4% |
| 6 | PHARMA DRUGS AND MEDI LIPEZ EZETIMIBE 10MG 3X10T ACC SIN AS PER INV | 1 | $68.1K | 2.2% |
| 7 | PH.DRU.& MED.: LIPEZ EZETIMIBE 10MG TABLETS (EACH UNCOATED TABLET CONTAINS: EZETIMIBE 10MG) [3X10T PER PACK] | 6 | $38.1K | 1.2% |
| 8 | PHARMA DRUGS AND MEDI LIPEZ EZETIMIBE 10 | 1 | $30.6K | 1.0% |
| 9 | PHARMA DRUGS AND MEDI LIPEZ EZETIMIBE 10MG 3X10T AS PER INV | 6 | $30.5K | 1.0% |
| 10 | PHARM DRUG&MED:ALVOTROL EZETIMIBE 10MG 3X10T ENTREP-SIN EACH UNCOATED TABLET CONTAINS: EZETIMIBE ##. 10 MG | 2 | $18.8K | 0.6% |
Showing top 10 of 116 Ezetimibe formulations imported by Singapore on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 115 shipments. Transit time averages 30 days by sea.
Market Dynamics
India's ezetimibe exports to Singapore are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 36 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 31 active exporters signals a competitive but concentrated market — buyers in Singapore benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, MEDREICH LIMITED — together account for 97% of total trade value on this route. The average shipment value of $9.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma drugs and medi lipez ezetimibe 10mg 3x10t(acc-sin) each uncoated tablet contains: ezetimibe 10 mg and ph.dru.& med.: lipez ezetimibe 10mg tablets each tablets contains: ezetimibe 10mg [3x10t per pack], suggesting that buyers in Singapore tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ACCORD HEALTHCARE PTE LTD is the largest importer with 29 shipments worth $2.8M USD — representing 87% of all ezetimibe imports from India on this route. A total of 62 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.2M
- Avg. Shipment
- $9.0K
- Suppliers
- 31
- Buyers
- 62
- Transit (Sea)
- ~30 days
- Annual Growth
- +25.0%
Other Ezetimibe Routes
Unlock the Full India to Singapore Ezetimibe Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 353 shipments on this route.
Frequently Asked Questions — India to Singapore Ezetimibe Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ezetimibe to Singapore?
The leading Indian exporters of Ezetimibe to Singapore are INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, MEDREICH LIMITED. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 92% of total trade value on this route.
Q What is the total value of Ezetimibe exports from India to Singapore?
India exports Ezetimibe to Singapore worth approximately $3.2M USD across 353 recorded shipments. The average value per shipment is $9.0K USD.
Q Which ports does India use to ship Ezetimibe to Singapore?
The most active port of origin is SAHAR AIR with 115 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Singapore for Ezetimibe?
The average transit time for Ezetimibe shipments from India to Singapore is approximately 30 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Singapore Ezetimibe trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.0% with demand growth tracking at 22.9%. The route is ranked #3 among India's top Ezetimibe export destinations globally.
Q How many suppliers are active on the India to Singapore Ezetimibe route?
There are currently 31 active Indian suppliers exporting Ezetimibe to Singapore. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 92% of total shipment value.
Q Who are the main importers of Ezetimibe from India in Singapore?
The leading importers of Indian Ezetimibe in Singapore include ACCORD HEALTHCARE PTE LTD, ACCORD HEALTHCARE PTE LIMITED, ABBOT LABORATORIES PTE LTD, ACCORD HEALTHCARE PTE LTD , ABBOT LABORATORIES PTE LIMITED. ACCORD HEALTHCARE PTE LTD is the largest buyer with 29 shipments worth $2.8M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Singapore export trade corridor identified from Indian Customs (DGFT) records for Ezetimibe.
- 2.Supplier/Buyer Matching: 31 Indian exporters and 62 importers in Singapore matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 353 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
353 Verified Shipments
31 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists